Basic information
- CAS
3159-07-7- Standard SMILES
O=C1Nc2ccccc2Sc2ccccc21- InChIKey
RTERDTBXBYNZIS-UHFFFAOYSA-N- Molecular formula
- C13H9NOS
- Average molar mass
- 227.28 g/mol
- Monoisotopic mass
- 227.04048508
Names & identifiers
- Preferred name
- Dibenzothiazepinone
- IUPAC
- 5H-benzo[b][1,4]benzothiazepin-6-one
- English name
- 10,11-Dihydro-11-oxodibenzo[b,f][1,4]thiazepine
- Molecular formula
- C13H9NOS
- Molecular weight
- 227.28
Names & synonyms
Show more names
Database identifiers
- CAS
3159-07-7- PubChem CID
- 374829
- DTXSID
DTXSID10953553- ChEMBL
CHEMBL598054- UNII
- FL6FG1E3WF
- EC Number
- 438-020-0、608-646-0
- Nikkaji
- J1.410.142J
Properties
Computed structural properties
- XLogP
- 2.9
- Topological polar surface area
- 54.4 Ų
- Hydrogen bond donors
- 1
- Hydrogen bond acceptors
- 2
- Rotatable bonds
- 0
- Heavy atoms
- 16
- Formal charge
- 0
- Complexity
- 281
Experimental & physicochemical properties
Physicochemical properties
- Melting point
- 265 °C · 265 °C
- Boiling point
- 309.2 · 309.2±12.0 °C(Predicted)
- Density
- 1.292 · 1.292±0.06 g/cm3(Predicted)
- storage temp.
- 2 · Keep in dark place,Sealed in dry,2-8°C
- solubility
- DMSO (Slightly, Heated)
- form
- Solid
- pka
- 12.4 · 12.40±0.20(Predicted)
- color
- White to Off-White
- Major Application
- pharmaceutical
- InChI
- InChI=1S/C13H9NOS/c15-13-9-5-1-3-7-11(9)16-12-8-4-2-6-10(12)14-13/h1-8H,(H,14,15)
- InChIKey
- RTERDTBXBYNZIS-UHFFFAOYSA-N
- SMILES
- S1C2=CC=CC=C2C(=O)NC2=CC=CC=C12
- CAS DataBase Reference
- 3159 · 3159-07-7(CAS DataBase Reference)
- FDA UNII
- 6 FG1E3WF · FL6FG1E3WF
- UNSPSC Code
- 41116107 · 41116107
- NACRES
- 24 · NA.24
- Symbol(GHS)
- 7 · GHS07
- Signal word
- Warning
- Hazard statements
- 302 · H302-H315-H319-H335
- Precautionary statements
- 261 · P261-P305+P351+P338
- Risk Statements
- 36 · 36/37/38
- Safety Statements
- 26 · 26-36/37/39
- WGK Germany
- 3 · WGK 3
- HS Code
- 2934990002 · 2934990002
- Storage Class
- 11 · 11 - Combustible Solids
- REACH Registrations
- Active
Safety & regulation
GHS classification
GHS Classification
This chemical does not meet GHS hazard criteria for 70% (7 of 10) of all reports.
Warning
H302 (20%): Harmful if swallowed [Warning Acute toxicity, oral];H315 (10%): Causes skin irritation [Warning Skin corrosion/irritation];H319 (10%): Causes serious eye irritation [Warning Serious eye damage/eye irritation];H335 (10%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation];H413 (10%): May cause long lasting harmful effects to aquatic life [Hazardous to the aquatic environment, long-term hazard]
P261, P264, P264+P265, P270, P271, P273, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 10 reports by companies from 4 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.;Reported as not meeting GHS hazard criteria per 7 of 10 reports by companies.;There are 3 notifications provided by 3 of 10 reports by companies with hazard statement code(s).;Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website.
Hazard information
Regulatory Information
Status: Cease Manufacture Update: 25-10-2012 https://echa.europa.eu/registration-dossier/-/registered-dossier/13051;Status: Active Update: 24-06-2010 https://echa.europa.eu/registration-dossier/-/registered-dossier/1433;Status: Active Update: 04-02-2021 https://echa.europa.eu/registration-dossier/-/registered-dossier/17252
Status: Active Update: 22-05-2018 https://echa.europa.eu/registration-dossier/-/registered-dossier/21491
Hazard Classes and Categories
Acute Tox. 4 (20%);Skin Irrit. 2 (10%);Eye Irrit. 2A (10%);STOT SE 3 (10%);Aquatic Chronic 4 (10%)
Skin Irrit. 2 (16.7%);Eye Irrit. 2 (16.7%);STOT SE 3 (16.7%);Aquatic Chronic 4 (83.3%)
Regulatory information
Regulatory Information
Status: Cease Manufacture Update: 25-10-2012 https://echa.europa.eu/registration-dossier/-/registered-dossier/13051;Status: Active Update: 24-06-2010 https://echa.europa.eu/registration-dossier/-/registered-dossier/1433;Status: Active Update: 04-02-2021 https://echa.europa.eu/registration-dossier/-/registered-dossier/17252
Status: Active Update: 22-05-2018 https://echa.europa.eu/registration-dossier/-/registered-dossier/21491
Safety data
- wgk
- WGK 3
- hs_code
- 2934990002
- risk_code
- 36/37/38
- Signal word
- Warning
- Symbol(GHS)
- GHS07
- safety_code
- 26-36/37/39
- Storage Class
- 11 - Combustible Solids
- Hazard statements
- H302-H315-H319-H335
- REACH Registrations
- Active
- Precautionary statements
- P261-P305+P351+P338
Chemistry & industry
Applications
UsesDibenzo[b,f][1,4]thiazepine-11-[10H]one (Quetiapine EP Impurity G; Quetiapine Impurity G; Quetiapine USP-G) is an intermediate in the synthesis of quetiapine (Q510000).
Upstream & downstream products
Downstream products
Suppliers100 total
Related reactions
Compound notes
Loading…